
Perimenopause UK 2026: Symptoms, Tests & When Private Care Is Worth It
Perimenopause typically starts in your early 40s but is routinely missed by NHS GPs. Here's how symptoms are actually assessed in 2026, which blood tests are useful (and which are not), and when a private menopause clinic is worth the money.
Take a Seat Clinical Team
19 July 2026 · 8 min read
Perimenopause UK 2026: Symptoms, Tests & When Private Care Is Worth It
Perimenopause is the 4 to 10 year window before your final period. It affects roughly 13 million women in the UK at any time, yet the average woman sees her GP three times before the connection is made. This guide covers what perimenopause actually looks like in 2026, which tests are useful, and where private care genuinely earns its fee.
The symptoms that actually predict perimenopause
NICE NG23 lists vasomotor symptoms (hot flushes, night sweats) as classic markers, but the strongest early predictors are usually cognitive and mood:
- Cycle changes (shorter, heavier, skipped)
- New-onset anxiety or low mood, often worse premenstrually
- Sleep fragmentation, especially 2 to 4am waking
- Word-finding difficulty and "brain fog"
- Joint pain, particularly hands and shoulders
- Reduced libido and vaginal dryness
If three or more of these appeared in your 40s, perimenopause is the most likely explanation regardless of whether your periods have stopped.
Which tests are actually useful
- FSH and oestradiol: Not diagnostic in women over 45 with typical symptoms. NICE explicitly advises against them.
- Thyroid (TSH, free T4): Useful, because hypothyroidism mimics perimenopause.
- Ferritin and vitamin D: Fatigue and low mood often improve dramatically when these are corrected.
- HbA1c and lipids: Worth a baseline; cardiovascular risk rises sharply post-menopause.
- AMH: Rarely useful clinically, it predicts ovarian reserve, not symptoms.
Our private blood test guide explains sensible panels and what to skip.
HRT in 2026: what's changed
Body-identical HRT (transdermal oestradiol + micronised progesterone) is now the NHS first-line, and the £19.80 annual HRT PPC covers all your prescriptions for 12 months. Testosterone remains off-licence for women but is prescribed by most menopause specialists for persistent low libido after 3 months of adequate oestrogen.
Full details, dose ranges and prescribing rules are in our menopause clinic pillar guide.
When private care is worth it
Going private is genuinely worth the money if:
- Your GP has refused testosterone or told you HRT "isn't safe" (both outdated)
- You have complex history, migraine with aura, breast cancer in the family, previous VTE
- You want more than 10 minutes to talk through the trade-offs
- You need a written plan you can hand to your NHS GP for shared care
Typical private consultation: £220, £380, with follow-ups every 3 to 6 months at £150, £220. Add £15, £40/month for private prescriptions if your GP won't take over.
Red flags: clinics to avoid
- Prescribing compounded "bioidentical" (cBHRT) creams, unregulated and not recommended by the British Menopause Society
- Charging for FSH testing to "confirm" perimenopause in women over 45
- Refusing to write to your GP
- No named prescriber on the website
FAQs
Can I get HRT without a private consultation? Yes. NHS GPs prescribe it, and NICE explicitly authorises it based on symptoms alone in women over 45.
Does HRT cause breast cancer? The absolute increased risk on combined HRT is around 5 extra cases per 1,000 women over 7.5 years, smaller than the increase from moderate alcohol intake. Oestrogen-only HRT (after hysterectomy) does not raise breast cancer risk.
Is testosterone safe long-term? Blood levels are monitored every 6 to 12 months; there is no evidence of long-term harm at physiological female doses.
Start with our free menopause screening or see our verified menopause specialists.
Keep exploring hormonal health
Curated by our clinical team